Our data are consistent with reports that a PTEN-loss gene signature, derived from a comparison of PTEN+/− tumors by IHC, is also associated with the luminal B subtype [5] and with a poor recurrence-free survival after Tam in ER+ breast cancer patients [32]. This evidence concerns the gene PTEN and breast carcinoma.